Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 7/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 6/20 | 0.41 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16848194 | 0.89 | AOC3 (0.49) | AOC3NPC1PKMRAB9AF10 | |
| SCHEMBL16848246 | 0.85 | AOC3 (0.48) | AOC3NPC1PKMRAB9AF10 | |
| SCHEMBL16848200 | 0.84 | AOC3 (0.52) | AOC3NPC1PKMRAB9AF10 | |
| SCHEMBL16827418 | 0.84 | AOC3 (0.47) | AOC3NPC1PKMRAB9AF10 | |
| SCHEMBL16848070 | 0.83 | AOC3 (0.46) | AOC3NPC1PKMRAB9ADRD2 | |
| SCHEMBL16827580 | 0.83 | AOC3 (0.46) | AOC3NPC1PKMRAB9AF10 | |
| SCHEMBL16848201 | 0.83 | AOC3 (0.49) | AOC3NPC1PKMRAB9AF10 | |
| SCHEMBL16848254 | 0.83 | NOX4 (0.51) | AOC3MAOBNPC1PKMRAB9A | |
| SCHEMBL16827362 | 0.81 | PDE4A (0.55) | AOC3NPC1PKMRAB9A | |
| SCHEMBL29438611 | 0.81 | PDE4A (0.55) | AOC3NPC1PKMRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015092634-A1 | 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS | NOVARTIS AG (CH) | 2015-06-25 | — | — | WO | disclosed |